New indications for Hepatitis B vaccination: It’s all in the new 2017 ACIP Adult Immunization Schedule, published in the Annals of Internal Medicine. Here’s what’s new for Hepatitis B vaccination. The list of chronic liver conditions for which Hepatitis B vaccination is indicated are specified Download a copy at: http://annals.org/aim/article/doi/10.7326/M16-2936
The new schedule specifies the list of chronic liver conditions that warrant Hepatitis B vaccination and includes Hepatitis C infection, cirrhosis, alcoholic liver disease, autoimmune hepatitis. It also includes those with Fatty liver disease and anyone with ALT or AST greater than twice normal.
Fatty liver (nonalcoholic) disease is the most common liver disorder in Western industrialized countries. Major risk factors include diabetes, high cholesterol, metabolic syndrome, and obesity. The CDC’s latest obesity numbers say 40% of US women and 35% of US men are obese (BMI of 30 or more). More than 5% of men and nearly 10% of women are morbidly obese (BMI of 40 or more). Those with fatty liver now need Hepatitis B vaccination. This new indication may mean many more adults need Hepatitis B vaccination.